data_2nav_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nav _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 . . . . . 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 20.1 mm-40 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' H ' HG23 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 110.906 -0.035 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.521 HG23 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.521 ' H ' HG23 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.516 HG21 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.516 ' H ' HG21 ' A' ' 18' ' ' ILE . 41.3 t60 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' OE1' HD11 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.421 HD11 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 . . . . . 0 CA--C 1.488 -1.412 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.44 ' H ' HG23 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m . . . . . 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.472 ' H ' HG22 ' A' ' 18' ' ' ILE . 48.8 t60 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' H ' HG23 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m . . . . . 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 120.414 0.15 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.522 HG21 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.522 ' H ' HG21 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 27.9 t70 . . . . . 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' HZ1' ' HB3' ' A' ' 12' ' ' LYS . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.439 ' OE1' HD11 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.506 HG21 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.506 ' H ' HG21 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG23 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.407 ' H ' HG23 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.44 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 . . . . . 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 . . . . . 0 CA--C 1.491 -1.3 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' H ' HG23 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.4 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.31 -127.24 1.62 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.69 -178.66 7.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.67 54.75 3.78 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.393 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.4 m -79.07 -62.55 1.66 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 117.073 0.437 . . . . 0.0 111.173 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -121.9 114.31 20.83 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -101.98 -19.28 15.29 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.406 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -69.15 10.62 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.07 126.12 28.16 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.07 94.49 4.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -107.69 103.78 13.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.4 m -129.73 -170.83 2.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.569 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -99.92 82.43 2.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.995 0.426 . . . . 0.0 110.251 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.439 0 CA-C-N 116.487 -0.324 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 CA--C 1.5 -0.97 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -146.98 27.94 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.13 100.24 8.95 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.29 -79.56 0.7 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.206 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -123.47 -37.65 2.63 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.428 0.632 . . . . 0.0 110.171 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.35 108.51 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -99.65 -32.68 10.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 t -92.39 36.06 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.289 0.566 . . . . 0.0 109.775 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 -65.44 126.89 29.68 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 20.1 mm-40 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m -119.33 99.81 6.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -84.61 100.58 11.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -100.07 161.13 13.8 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.197 -173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -63.31 93.49 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.568 0.747 . . . . 0.0 112.596 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.438 0 O-C-N 122.0 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.29 -135.85 4.53 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -117.65 136.75 53.11 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.68 62.62 2.23 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -59.61 -43.19 93.83 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -103.06 130.53 50.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.712 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -55.33 -44.76 76.19 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.151 0.98 . . . . 0.0 112.739 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -90.08 24.6 2.42 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.75 140.78 53.49 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.72 95.23 3.1 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -89.66 121.29 31.7 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.003 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m -95.94 13.93 25.27 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.79 0.805 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -75.37 97.71 3.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.06 64.42 0.49 Allowed Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.2 158.04 15.62 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.28 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.25 -122.86 5.16 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.901 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 m -74.1 -57.65 3.82 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -138.91 123.47 18.45 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -121.18 -3.76 9.51 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.927 0.87 . . . . 0.0 109.338 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -87.28 16.45 5.25 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.844 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 -60.78 134.3 56.95 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.818 0.847 . . . . 0.0 111.726 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.443 ' H ' HG23 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m -109.06 109.18 20.14 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -101.87 99.21 9.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 m -101.14 -20.06 15.48 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.073 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.5 tpm_? 47.21 83.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.98 -39.57 74.25 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.57 152.88 41.17 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 172.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 45.82 5.64 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -70.95 -30.5 66.82 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.719 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.081 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 9' ' ' ASP . 12.0 t -91.14 -17.09 26.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 m -83.76 23.69 0.96 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.958 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -57.71 139.33 54.08 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.963 1.305 . . . . 0.0 110.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.521 HG23 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.521 ' H ' HG23 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -116.45 81.37 1.61 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -108.78 100.69 9.88 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.8 m -133.78 29.92 3.78 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.372 0.606 . . . . 0.0 110.615 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -75.66 -74.56 0.21 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.091 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 116.703 -0.226 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 m80 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.29 -17.49 40.41 Favored Glycine 0 C--O 1.246 0.891 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.06 119.9 12.21 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.99 -1.105 . . . . 0.0 108.633 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.75 -48.82 0.9 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -75.41 -46.98 29.48 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -107.65 107.51 18.34 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -89.34 -24.52 21.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.482 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.2 m -81.39 45.5 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.194 0.521 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.78 163.02 7.9 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.072 1.349 . . . . 0.0 112.251 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.516 HG21 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.516 ' H ' HG21 ' A' ' 18' ' ' ILE . 41.3 t60 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m -135.14 72.05 1.45 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -107.66 100.57 9.95 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 m -139.28 164.56 29.5 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.4 ptm85 -117.62 86.93 2.61 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.483 0.658 . . . . 0.0 110.429 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.5 m80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.61 172.43 13.15 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -99.89 173.36 6.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 120.917 0.389 . . . . 0.0 110.285 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.44 44.79 1.43 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.8 m -83.45 -44.75 14.42 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.268 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -130.0 107.78 9.6 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -76.42 -23.77 53.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -87.76 16.72 5.42 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 -74.89 113.08 11.77 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' OE1' HD11 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 HD11 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m -116.82 117.03 28.61 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -107.65 100.56 9.95 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 m -101.58 142.79 32.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -70.4 -87.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 116.709 -0.223 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.58 -172.55 52.47 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 116.502 -0.317 . . . . 0.0 113.241 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.84 124.4 29.65 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.95 28.59 0.65 Allowed Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.372 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.3 m -142.58 -61.38 0.44 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.866 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -168.59 118.24 0.73 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -94.82 -15.16 23.97 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.897 0.38 . . . . 0.0 111.28 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.5 m -110.39 27.33 9.74 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 -86.26 118.23 25.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.119 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.44 ' H ' HG23 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m -117.94 75.75 1.02 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -96.53 100.24 11.84 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.65 163.24 30.2 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.735 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -107.58 96.34 6.33 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.572 0.701 . . . . 0.0 111.717 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.59 80.25 0.28 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.003 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.76 154.35 0.12 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.767 1.227 . . . . 0.0 111.962 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.69 50.17 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.347 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -109.64 -64.77 1.21 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.27 0.557 . . . . 0.0 110.326 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 15.5 t80 -95.51 129.03 42.83 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.438 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -140.98 12.03 2.22 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.945 0.878 . . . . 0.0 108.936 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 20.8 t -80.68 0.51 34.05 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.855 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.62 118.49 5.7 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.472 ' H ' HG22 ' A' ' 18' ' ' ILE . 48.8 t60 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.65 77.35 1.08 Allowed 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -107.93 108.28 19.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.3 m -138.36 157.08 46.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.316 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -70.65 -62.69 1.3 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.633 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.108 0 O-C-N 122.167 -0.333 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.64 -64.06 3.1 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -81.94 105.11 12.8 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 -4.07 60.64 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 m -72.52 -44.9 61.57 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.96 -0.62 . . . . 0.0 111.221 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -132.73 131.01 40.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.516 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -131.69 -5.96 3.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 m -74.19 30.55 0.08 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.607 0.763 . . . . 0.0 112.814 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 -71.64 135.07 46.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m -107.38 93.23 4.43 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.03 100.22 9.58 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.9 m -141.26 103.69 4.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -132.38 113.0 12.66 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.297 0.57 . . . . 0.0 112.077 -176.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.92 -140.37 9.11 Favored Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.236 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.52 -27.22 21.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.635 0.731 . . . . 0.0 109.818 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.75 92.41 0.3 Allowed Glycine 0 C--N 1.286 -2.207 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.976 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.1 m -67.75 -33.39 74.76 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.21 0.529 . . . . 0.0 110.814 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -137.86 149.14 46.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -52.46 -50.75 62.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.082 0.953 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -76.71 96.75 4.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 -108.16 127.42 53.8 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.141 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' H ' HG23 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m -112.21 96.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.75 102.82 15.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.0 m -80.29 150.56 29.93 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.46 90.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.076 1.351 . . . . 0.0 112.154 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.282 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 160.14 14.85 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.061 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 17.08 3.41 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.04 57.07 0.56 Allowed Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.761 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.3 m -68.12 -44.48 76.03 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.616 0.722 . . . . 0.0 110.405 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -128.0 116.52 20.17 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -110.27 -15.98 13.85 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.108 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -81.81 14.57 2.62 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 -54.01 129.31 33.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 122.636 0.374 . . . . 0.0 110.734 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.522 HG21 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.522 ' H ' HG21 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.1 69.83 3.84 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -108.4 101.67 10.84 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.869 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.2 m -114.67 154.15 28.94 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.96 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -83.79 82.5 8.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.459 0.647 . . . . 0.0 111.405 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.415 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . 38.2 t60 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.6 17.2 34.18 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.951 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' CD ' ' H3 ' ' A' ' 1' ' ' HIS . 4.3 mp0 -60.05 143.44 51.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 122.853 0.461 . . . . 0.0 110.592 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.78 -50.38 1.38 Allowed Glycine 0 C--N 1.298 -1.531 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.3 m -79.08 -44.71 21.57 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -131.2 122.11 26.0 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.401 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' SER . 2.5 t -108.61 -48.64 3.28 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 7' ' ' THR . 15.1 t 163.63 97.85 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.728 . . . . 0.0 107.956 173.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 -92.38 120.26 32.71 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m -129.61 116.04 18.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -108.0 99.27 8.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.4 m -146.67 163.62 35.3 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -71.46 -74.24 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 123.824 0.702 . . . . 0.0 110.948 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.83 -7.47 12.03 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.76 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 73.71 85.68 0.11 Allowed 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.493 1.117 . . . . 0.0 111.74 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.25 131.78 3.94 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -62.34 -42.68 99.59 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.317 0.647 . . . . 0.0 110.328 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -121.15 138.17 54.33 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -59.74 -50.53 73.47 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.508 0.505 . . . . 0.0 110.804 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 m -85.03 35.27 0.57 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 -73.21 113.42 10.25 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m -132.02 139.26 48.53 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -107.53 98.59 8.18 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.83 30.67 6.12 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.053 0.93 . . . . 0.0 108.551 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -68.37 104.29 1.84 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.175 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 116.757 -0.201 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.593 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.497 ' OE1' ' HB ' ' A' ' 5' ' ' THR . 10.5 pt-20 -104.67 158.98 16.13 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.01 23.0 6.26 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 56.4 m -87.15 -69.04 0.71 Allowed 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.532 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -109.58 149.67 29.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.635 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -64.55 -44.96 89.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.694 1.198 . . . . 0.0 112.27 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.7 t -74.99 100.92 4.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.61 0.719 . . . . 0.0 110.778 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 27.9 t70 -143.72 123.43 13.36 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 173.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' HB2' ' OD2' ' A' ' 9' ' ' ASP . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' HZ1' ' HB3' ' A' ' 12' ' ' LYS . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.439 ' OE1' HD11 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.576 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.506 HG21 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.506 ' H ' HG21 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m -101.54 82.65 2.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -107.41 100.17 9.63 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.6 m -140.38 -64.0 0.48 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.254 1.026 . . . . 0.0 111.094 -173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 14' ' ' CYS . 5.6 ptm180 -146.04 92.45 2.2 Favored 'General case' 0 C--N 1.259 -3.338 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.546 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.247 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.48 162.44 28.61 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -81.03 138.56 36.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.29 37.82 0.4 Allowed Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -57.73 -47.33 82.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.535 0.734 . . . . 0.0 109.859 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -133.51 139.91 46.92 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -65.47 -25.09 67.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.373 0.606 . . . . 0.0 111.043 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -105.13 32.51 4.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.263 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 -70.26 94.47 0.92 Allowed 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG23 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.407 ' H ' HG23 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.44 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m -136.15 87.83 2.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -95.6 100.17 11.94 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.96 123.11 25.3 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.582 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -81.66 98.5 8.41 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.351 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.91 71.63 2.71 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.804 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' OE2' ' HB ' ' A' ' 5' ' ' THR . 11.4 tp10 -120.41 92.72 3.84 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.835 0.826 . . . . 0.0 110.23 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.16 23.44 4.11 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.418 ' HB ' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -89.87 -46.49 8.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -120.49 147.59 44.93 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -147.42 -22.41 0.38 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 m -71.91 77.74 0.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.758 0.79 . . . . 0.0 112.916 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 -115.25 133.87 55.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m -116.81 87.94 2.8 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -107.73 99.87 9.31 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 m -142.39 -174.76 4.22 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 15' ' ' GLU . 13.0 mmt180 53.2 -91.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.414 . . . . 0.0 113.478 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.263 0 O-C-N 122.064 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 94.46 1.12 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 75.54 162.63 0.25 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.183 1.393 . . . . 0.0 112.45 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.35 25.57 2.87 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -71.26 -51.73 22.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.756 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -135.62 145.8 47.23 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.975 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 7' ' ' THR . 20.3 m -143.16 14.18 1.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.498 1.142 . . . . 0.0 109.344 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t 63.15 39.45 9.85 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.36 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 -68.04 119.1 12.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.754 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.65 109.26 12.94 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -98.98 100.31 11.46 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.6 m -104.52 167.48 9.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -81.54 87.47 6.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.0 110.094 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 116.733 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 154.89 25.15 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.82 152.55 20.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.6 0.7 . . . . 0.0 111.384 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.58 36.67 0.22 Allowed Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -77.04 -48.98 16.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.891 -0.654 . . . . 0.0 110.406 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 32.3 t80 -135.6 134.89 39.79 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.391 -171.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -140.76 11.99 2.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.613 0.721 . . . . 0.0 109.838 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 22.8 m -85.97 21.79 1.87 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.873 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 -63.35 99.58 0.2 Allowed 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' H ' HG23 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 24' ' ' PHE . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m -132.91 71.95 1.48 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -107.51 105.78 15.84 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -133.44 127.72 33.94 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -62.97 103.52 0.46 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 O-C-N 122.142 -0.349 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 78.5 t60 . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.2 67.94 1.52 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -83.22 126.61 32.83 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.827 -0.687 . . . . 0.0 112.509 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.51 -68.11 0.79 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.7 m -89.56 -74.86 0.46 Allowed 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.876 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 5.1 t80 -155.23 119.97 4.79 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.071 0.462 . . . . 0.0 110.292 -170.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 m -55.59 -43.55 76.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.602 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 14.6 m -94.32 38.9 1.09 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.065 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -55.92 121.38 9.16 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.24 105.91 9.86 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.8 171.51 7.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.06 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -78.12 96.38 5.14 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 109.8 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 116.534 -0.303 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 . . . . . 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 9.6 mm100 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 20' ' ' HIS . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.464 ' H ' HG22 ' A' ' 18' ' ' ILE . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' H ' HG22 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 110.906 -0.035 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.627 HG22 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.627 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.0 t-80 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' OE1' HD12 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 . . . . . 0 CA--C 1.488 -1.412 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.533 ' H ' HG22 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m . . . . . 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 18' ' ' ILE . 58.6 t-80 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m . . . . . 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 120.414 0.15 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.632 ' H ' HG22 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.439 ' H ' HG22 ' A' ' 18' ' ' ILE . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 19' ' ' GLY . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 21' ' ' LYS . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.682 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.446 ' OE1' HD12 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.582 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 . . . . . 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 20' ' ' HIS . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' ILE . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 . . . . . 0 CA--C 1.491 -1.3 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.509 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.31 -127.24 1.62 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.69 -178.66 7.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.67 54.75 3.78 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.393 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.4 m -79.07 -62.55 1.66 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 117.073 0.437 . . . . 0.0 111.173 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -121.9 114.31 20.83 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -101.98 -19.28 15.29 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.406 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -69.15 10.62 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.07 126.12 28.16 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.07 94.49 4.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -107.69 103.78 13.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.4 m -129.73 -170.83 2.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.569 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -99.92 82.43 2.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.995 0.426 . . . . 0.0 110.251 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.439 0 CA-C-N 116.487 -0.324 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 CA--C 1.5 -0.97 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -146.98 27.94 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.13 100.24 8.95 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.29 -79.56 0.7 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.206 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -123.47 -37.65 2.63 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.428 0.632 . . . . 0.0 110.171 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.35 108.51 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -99.65 -32.68 10.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 t -92.39 36.06 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.289 0.566 . . . . 0.0 109.775 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 -65.44 126.89 29.68 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 9.6 mm100 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 20' ' ' HIS . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.464 ' H ' HG22 ' A' ' 18' ' ' ILE . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m -119.33 99.81 6.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -84.61 100.58 11.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -100.07 161.13 13.8 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.197 -173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -63.31 93.49 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.568 0.747 . . . . 0.0 112.596 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.438 0 O-C-N 122.0 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.29 -135.85 4.53 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -117.65 136.75 53.11 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.68 62.62 2.23 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -59.61 -43.19 93.83 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 9.2 t80 -103.06 130.53 50.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.712 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -55.33 -44.76 76.19 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.151 0.98 . . . . 0.0 112.739 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -90.08 24.6 2.42 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.75 140.78 53.49 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.72 95.23 3.1 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -89.66 121.29 31.7 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.003 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m -95.94 13.93 25.27 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.79 0.805 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -75.37 97.71 3.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.06 64.42 0.49 Allowed Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.2 158.04 15.62 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.28 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.25 -122.86 5.16 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.901 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 m -74.1 -57.65 3.82 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -138.91 123.47 18.45 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -121.18 -3.76 9.51 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.927 0.87 . . . . 0.0 109.338 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -87.28 16.45 5.25 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.844 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 -60.78 134.3 56.95 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.818 0.847 . . . . 0.0 111.726 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' H ' HG22 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m -109.06 109.18 20.14 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -101.87 99.21 9.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 m -101.14 -20.06 15.48 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.073 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.5 tpm_? 47.21 83.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.98 -39.57 74.25 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.57 152.88 41.17 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 172.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 45.82 5.64 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -70.95 -30.5 66.82 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.719 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.081 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -91.14 -17.09 26.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.414 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 24.1 m -83.76 23.69 0.96 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.958 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -57.71 139.33 54.08 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.963 1.305 . . . . 0.0 110.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -116.45 81.37 1.61 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -108.78 100.69 9.88 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.8 m -133.78 29.92 3.78 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.372 0.606 . . . . 0.0 110.615 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -75.66 -74.56 0.21 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.091 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 116.703 -0.226 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 m80 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.29 -17.49 40.41 Favored Glycine 0 C--O 1.246 0.891 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.06 119.9 12.21 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.99 -1.105 . . . . 0.0 108.633 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.75 -48.82 0.9 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -75.41 -46.98 29.48 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -107.65 107.51 18.34 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -89.34 -24.52 21.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.482 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.2 m -81.39 45.5 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.194 0.521 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.78 163.02 7.9 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.072 1.349 . . . . 0.0 112.251 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.627 HG22 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.627 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.0 t-80 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m -135.14 72.05 1.45 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -107.66 100.57 9.95 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 m -139.28 164.56 29.5 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.4 ptm85 -117.62 86.93 2.61 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.483 0.658 . . . . 0.0 110.429 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.5 m80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.61 172.43 13.15 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -99.89 173.36 6.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 120.917 0.389 . . . . 0.0 110.285 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.44 44.79 1.43 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.8 m -83.45 -44.75 14.42 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.268 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -130.0 107.78 9.6 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -76.42 -23.77 53.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -87.76 16.72 5.42 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 -74.89 113.08 11.77 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' OE1' HD12 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m -116.82 117.03 28.61 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -107.65 100.56 9.95 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 m -101.58 142.79 32.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -70.4 -87.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 116.709 -0.223 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.58 -172.55 52.47 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 116.502 -0.317 . . . . 0.0 113.241 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.84 124.4 29.65 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.95 28.59 0.65 Allowed Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.372 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.3 m -142.58 -61.38 0.44 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.866 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -168.59 118.24 0.73 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -94.82 -15.16 23.97 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.897 0.38 . . . . 0.0 111.28 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.5 m -110.39 27.33 9.74 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 -86.26 118.23 25.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.119 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.533 ' H ' HG22 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m -117.94 75.75 1.02 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -96.53 100.24 11.84 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.65 163.24 30.2 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.735 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -107.58 96.34 6.33 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.572 0.701 . . . . 0.0 111.717 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.59 80.25 0.28 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.003 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.76 154.35 0.12 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.767 1.227 . . . . 0.0 111.962 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.69 50.17 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.347 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -109.64 -64.77 1.21 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.27 0.557 . . . . 0.0 110.326 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 15.5 t80 -95.51 129.03 42.83 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.438 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -140.98 12.03 2.22 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.945 0.878 . . . . 0.0 108.936 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 20.8 t -80.68 0.51 34.05 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.855 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.62 118.49 5.7 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 18' ' ' ILE . 58.6 t-80 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.65 77.35 1.08 Allowed 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -107.93 108.28 19.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.3 m -138.36 157.08 46.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.316 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -70.65 -62.69 1.3 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.633 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.108 0 O-C-N 122.167 -0.333 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.64 -64.06 3.1 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -81.94 105.11 12.8 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 -4.07 60.64 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 m -72.52 -44.9 61.57 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.96 -0.62 . . . . 0.0 111.221 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -132.73 131.01 40.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.516 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -131.69 -5.96 3.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 m -74.19 30.55 0.08 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.607 0.763 . . . . 0.0 112.814 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 -71.64 135.07 46.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m -107.38 93.23 4.43 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.03 100.22 9.58 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.9 m -141.26 103.69 4.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -132.38 113.0 12.66 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.297 0.57 . . . . 0.0 112.077 -176.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.92 -140.37 9.11 Favored Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.236 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.52 -27.22 21.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.635 0.731 . . . . 0.0 109.818 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.75 92.41 0.3 Allowed Glycine 0 C--N 1.286 -2.207 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.976 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.1 m -67.75 -33.39 74.76 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.21 0.529 . . . . 0.0 110.814 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -137.86 149.14 46.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -52.46 -50.75 62.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.082 0.953 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -76.71 96.75 4.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 -108.16 127.42 53.8 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.141 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m -112.21 96.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.75 102.82 15.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.0 m -80.29 150.56 29.93 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.46 90.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.076 1.351 . . . . 0.0 112.154 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.282 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 160.14 14.85 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.061 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 17.08 3.41 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.04 57.07 0.56 Allowed Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.761 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.3 m -68.12 -44.48 76.03 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.616 0.722 . . . . 0.0 110.405 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -128.0 116.52 20.17 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -110.27 -15.98 13.85 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.108 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -81.81 14.57 2.62 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 -54.01 129.31 33.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 122.636 0.374 . . . . 0.0 110.734 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.632 ' H ' HG22 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.1 69.83 3.84 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -108.4 101.67 10.84 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.869 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.2 m -114.67 154.15 28.94 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.96 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -83.79 82.5 8.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.459 0.647 . . . . 0.0 111.405 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.6 17.2 34.18 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.951 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.05 143.44 51.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 122.853 0.461 . . . . 0.0 110.592 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.78 -50.38 1.38 Allowed Glycine 0 C--N 1.298 -1.531 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.3 m -79.08 -44.71 21.57 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -131.2 122.11 26.0 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.401 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' SER . 2.5 t -108.61 -48.64 3.28 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 7' ' ' THR . 15.1 t 163.63 97.85 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.728 . . . . 0.0 107.956 173.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 -92.38 120.26 32.71 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.439 ' H ' HG22 ' A' ' 18' ' ' ILE . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m -129.61 116.04 18.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -108.0 99.27 8.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.4 m -146.67 163.62 35.3 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -71.46 -74.24 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 123.824 0.702 . . . . 0.0 110.948 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.83 -7.47 12.03 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.76 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 73.71 85.68 0.11 Allowed 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.493 1.117 . . . . 0.0 111.74 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.25 131.78 3.94 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -62.34 -42.68 99.59 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.317 0.647 . . . . 0.0 110.328 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -121.15 138.17 54.33 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -59.74 -50.53 73.47 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.508 0.505 . . . . 0.0 110.804 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 m -85.03 35.27 0.57 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 -73.21 113.42 10.25 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 19' ' ' GLY . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 21' ' ' LYS . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.682 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m -132.02 139.26 48.53 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -107.53 98.59 8.18 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.83 30.67 6.12 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.053 0.93 . . . . 0.0 108.551 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -68.37 104.29 1.84 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.175 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 116.757 -0.201 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.593 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' OE1' ' HB ' ' A' ' 5' ' ' THR . 10.5 pt-20 -104.67 158.98 16.13 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.01 23.0 6.26 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.507 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 56.4 m -87.15 -69.04 0.71 Allowed 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.532 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -109.58 149.67 29.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.635 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -64.55 -44.96 89.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.694 1.198 . . . . 0.0 112.27 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.7 t -74.99 100.92 4.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.61 0.719 . . . . 0.0 110.778 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -143.72 123.43 13.36 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' OE1' HD12 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.582 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m -101.54 82.65 2.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -107.41 100.17 9.63 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.6 m -140.38 -64.0 0.48 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.254 1.026 . . . . 0.0 111.094 -173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HD3' ' O ' ' A' ' 14' ' ' CYS . 5.6 ptm180 -146.04 92.45 2.2 Favored 'General case' 0 C--N 1.259 -3.338 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.546 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.247 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.48 162.44 28.61 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -81.03 138.56 36.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.29 37.82 0.4 Allowed Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -57.73 -47.33 82.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.535 0.734 . . . . 0.0 109.859 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -133.51 139.91 46.92 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -65.47 -25.09 67.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.373 0.606 . . . . 0.0 111.043 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -105.13 32.51 4.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.263 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 -70.26 94.47 0.92 Allowed 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m -136.15 87.83 2.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -95.6 100.17 11.94 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.96 123.11 25.3 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.582 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -81.66 98.5 8.41 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.351 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.91 71.63 2.71 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.804 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -120.41 92.72 3.84 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.835 0.826 . . . . 0.0 110.23 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.16 23.44 4.11 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.9 m -89.87 -46.49 8.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -120.49 147.59 44.93 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -147.42 -22.41 0.38 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 m -71.91 77.74 0.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.758 0.79 . . . . 0.0 112.916 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 -115.25 133.87 55.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 20' ' ' HIS . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' ILE . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m -116.81 87.94 2.8 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -107.73 99.87 9.31 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 m -142.39 -174.76 4.22 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NH2' ' HA ' ' A' ' 15' ' ' GLU . 13.0 mmt180 53.2 -91.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.414 . . . . 0.0 113.478 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.263 0 O-C-N 122.064 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 94.46 1.12 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 75.54 162.63 0.25 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.183 1.393 . . . . 0.0 112.45 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.35 25.57 2.87 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -71.26 -51.73 22.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.756 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -135.62 145.8 47.23 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.975 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 20.3 m -143.16 14.18 1.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.498 1.142 . . . . 0.0 109.344 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t 63.15 39.45 9.85 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.36 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 -68.04 119.1 12.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.754 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.65 109.26 12.94 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -98.98 100.31 11.46 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.6 m -104.52 167.48 9.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -81.54 87.47 6.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.0 110.094 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 116.733 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 154.89 25.15 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.82 152.55 20.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.6 0.7 . . . . 0.0 111.384 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.58 36.67 0.22 Allowed Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -77.04 -48.98 16.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.891 -0.654 . . . . 0.0 110.406 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 32.3 t80 -135.6 134.89 39.79 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.391 -171.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -140.76 11.99 2.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.613 0.721 . . . . 0.0 109.838 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 22.8 m -85.97 21.79 1.87 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.873 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 -63.35 99.58 0.2 Allowed 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.509 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m -132.91 71.95 1.48 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -107.51 105.78 15.84 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -133.44 127.72 33.94 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -62.97 103.52 0.46 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 O-C-N 122.142 -0.349 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 78.5 t60 . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.2 67.94 1.52 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -83.22 126.61 32.83 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.827 -0.687 . . . . 0.0 112.509 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.51 -68.11 0.79 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.7 m -89.56 -74.86 0.46 Allowed 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.876 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 5.1 t80 -155.23 119.97 4.79 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.071 0.462 . . . . 0.0 110.292 -170.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 m -55.59 -43.55 76.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.602 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 14.6 m -94.32 38.9 1.09 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.065 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -55.92 121.38 9.16 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.24 105.91 9.86 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.8 171.51 7.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.06 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -78.12 96.38 5.14 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 109.8 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 116.534 -0.303 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 . . . . . 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 20.1 mm-40 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 20' ' ' HIS . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.464 ' H ' HG22 ' A' ' 18' ' ' ILE . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m . . . . . 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' H ' HG22 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 110.906 -0.035 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.24 0.563 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.627 HG22 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.627 ' H ' HG22 ' A' ' 18' ' ' ILE . 41.3 t60 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' OE1' HD12 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 . . . . . 0 CA--C 1.488 -1.412 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.533 ' H ' HG22 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m . . . . . 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 18' ' ' ILE . 48.8 t60 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m . . . . . 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 120.414 0.15 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.632 ' H ' HG22 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 . . . . . 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.439 ' H ' HG22 ' A' ' 18' ' ' ILE . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 . . . . . 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 19' ' ' GLY . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 21' ' ' LYS . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.682 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.446 ' OE1' HD12 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.582 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 . . . . . 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 20' ' ' HIS . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' ILE . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 . . . . . 0 CA--C 1.491 -1.3 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m . . . . . 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.509 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.31 -127.24 1.62 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.69 -178.66 7.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.67 54.75 3.78 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.393 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.4 m -79.07 -62.55 1.66 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 117.073 0.437 . . . . 0.0 111.173 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -121.9 114.31 20.83 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -101.98 -19.28 15.29 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.406 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -69.15 10.62 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -172.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.07 126.12 28.16 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.15 -45.29 93.57 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 123.49 0.494 . . . . 0.0 110.95 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 25.4 p -63.46 -33.89 76.55 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.089 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -74.74 -38.27 62.29 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.36 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -68.45 -35.07 77.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.229 0.537 . . . . 0.0 110.586 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.18 -36.24 71.88 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.812 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 11' ' ' SER . 54.1 mm-40 -69.29 -28.45 66.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.4 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.91 -26.12 61.31 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.203 0.525 . . . . 0.0 110.147 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.23 28.17 8.28 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.982 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.306 2.0 pt -105.95 -83.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.2 18.86 75.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 119.718 -1.229 . . . . 0.0 111.258 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -106.99 133.49 51.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 75.99 10.72 3.13 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 124.188 0.93 . . . . 0.0 110.046 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -125.61 91.62 48.25 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.83 -11.78 33.41 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.449 2.766 . . . . 0.0 113.623 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -103.54 7.77 37.73 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.152 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.07 94.49 4.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -107.69 103.78 13.14 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.4 m -129.73 -170.83 2.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.569 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -99.92 82.43 2.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.995 0.426 . . . . 0.0 110.251 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.439 0 CA-C-N 116.487 -0.324 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 CA--C 1.5 -0.97 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -146.98 27.94 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -81.13 100.24 8.95 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.29 -79.56 0.7 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.206 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -123.47 -37.65 2.63 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.428 0.632 . . . . 0.0 110.171 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -104.35 108.51 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -99.65 -32.68 10.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.043 0.449 . . . . 0.0 110.545 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 t -92.39 36.06 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.289 0.566 . . . . 0.0 109.775 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 29.9 t70 -65.44 126.89 29.68 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.46 -41.4 69.43 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.819 0.699 . . . . 0.0 111.488 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -70.1 -36.88 75.18 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.258 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.64 -35.44 80.16 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.412 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 20.1 mm-40 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.8 m -75.56 -35.24 60.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.758 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.38 -33.76 67.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.376 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.83 -19.27 60.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 34.1 26.76 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.641 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 20' ' ' HIS . 25.6 mt -86.31 -85.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.52 19.14 74.35 Favored Glycine 0 C--O 1.22 -0.727 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.095 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.464 ' H ' HG22 ' A' ' 18' ' ' ILE . 67.6 t60 -105.69 119.82 40.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 74.51 17.02 3.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.771 1.228 . . . . 0.0 111.353 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -122.6 87.64 49.5 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.17 -17.11 28.17 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 123.198 2.599 . . . . 0.0 112.736 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.7 3.3 52.5 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.204 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.4 m -119.33 99.81 6.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -84.61 100.58 11.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -100.07 161.13 13.8 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.197 -173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -63.31 93.49 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.568 0.747 . . . . 0.0 112.596 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.438 0 O-C-N 122.0 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 37.2 m80 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.088 0.47 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.29 -135.85 4.53 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -117.65 136.75 53.11 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.68 62.62 2.23 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -59.61 -43.19 93.83 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 9.2 t80 -103.06 130.53 50.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 118.817 -1.153 . . . . 0.0 110.712 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -55.33 -44.76 76.19 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.151 0.98 . . . . 0.0 112.739 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -90.08 24.6 2.42 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -69.75 140.78 53.49 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.2 t -52.13 -43.06 63.82 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.372 1.069 . . . . 0.0 112.006 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -66.93 -33.51 75.74 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.54 0.686 . . . . 0.0 109.947 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 30.1 mtpp -77.02 -26.16 53.45 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.861 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.73 -35.18 76.8 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.99 -8.93 56.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.505 0.669 . . . . 0.0 111.216 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 34.8 tt0 -79.35 -35.45 40.92 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -90.15 -22.99 21.46 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.528 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.96 53.91 3.57 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.118 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -97.96 -81.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.72 28.98 71.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.741 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -124.69 124.7 42.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 75.07 13.11 3.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.24 1.016 . . . . 0.0 111.204 -176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -125.01 82.39 61.55 Favored Pre-proline 0 C--N 1.316 -0.848 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.44 -30.0 53.15 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.279 1.986 . . . . 0.0 111.619 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -83.86 1.23 44.21 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -136.72 95.23 3.1 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 120.405 0.145 . . . . 0.0 110.853 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -89.66 121.29 31.7 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.003 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m -95.94 13.93 25.27 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.79 0.805 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -75.37 97.71 3.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.06 64.42 0.49 Allowed Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.2 158.04 15.62 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.28 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.25 -122.86 5.16 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.901 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 m -74.1 -57.65 3.82 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -138.91 123.47 18.45 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -121.18 -3.76 9.51 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.927 0.87 . . . . 0.0 109.338 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.4 m -87.28 16.45 5.25 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.844 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 12.3 m-20 -60.78 134.3 56.95 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.818 0.847 . . . . 0.0 111.726 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.4 t -59.59 -36.38 76.16 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.7 m -63.43 -33.8 76.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.945 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -75.86 -39.73 55.98 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.576 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.3 mm-40 -58.1 -44.53 87.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.718 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.6 m -77.49 -29.04 52.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.36 -34.94 75.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.63 -22.46 40.56 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.554 0.692 . . . . 0.0 109.61 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.99 45.46 6.3 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.53 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 20' ' ' HIS . 22.1 mt -104.22 -85.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.57 -10.29 18.22 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-O 121.549 0.527 . . . . 0.0 112.613 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' H ' HG22 ' A' ' 18' ' ' ILE . 50.2 t60 -79.05 117.94 20.56 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 123.808 0.843 . . . . 0.0 109.282 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 79.76 11.42 1.24 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.965 1.306 . . . . 0.0 112.172 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.82 87.66 54.76 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.24 -21.87 61.48 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.692 2.928 . . . . 0.0 114.124 -169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -89.27 -5.8 57.3 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.473 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.5 m -109.06 109.18 20.14 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.981 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -101.87 99.21 9.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 m -101.14 -20.06 15.48 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.073 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.5 tpm_? 47.21 83.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.616 0 CA-C-N 116.305 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.98 -39.57 74.25 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.57 152.88 41.17 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 172.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 45.82 5.64 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -70.95 -30.5 66.82 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.719 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.081 -175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -91.14 -17.09 26.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.414 ' HA ' ' NE2' ' A' ' 13' ' ' GLN . 24.1 m -83.76 23.69 0.96 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.958 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -57.71 139.33 54.08 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.963 1.305 . . . . 0.0 110.906 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.24 -35.85 67.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -70.08 -35.21 74.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.598 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -70.75 -36.14 72.99 Favored 'General case' 0 C--O 1.205 -1.239 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.919 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -64.03 -35.97 82.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.778 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 94.7 m -73.82 -35.43 64.85 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.135 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.12 -35.66 80.22 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.951 0.5 . . . . 0.0 110.402 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -75.13 -28.19 60.09 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.07 34.89 19.92 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 20' ' ' HIS . 53.0 mt -100.09 -82.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.25 -10.9 19.0 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.48 -0.39 . . . . 0.0 112.962 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' ILE . 30.3 t-80 -82.04 123.77 29.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 83.82 10.68 0.45 Allowed 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.552 1.541 . . . . 0.0 109.789 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.05 86.45 57.17 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.61 -4.2 9.25 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 124.215 3.277 . . . . 0.0 115.598 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -123.01 11.07 9.52 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 120.918 0.39 . . . . 0.0 111.241 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.3 m -116.45 81.37 1.61 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.146 0.498 . . . . 0.0 110.21 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -108.78 100.69 9.88 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.8 m -133.78 29.92 3.78 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 121.372 0.606 . . . . 0.0 110.615 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -75.66 -74.56 0.21 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.091 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 116.703 -0.226 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.9 m80 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.29 -17.49 40.41 Favored Glycine 0 C--O 1.246 0.891 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.06 119.9 12.21 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.99 -1.105 . . . . 0.0 108.633 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.75 -48.82 0.9 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.4 m -75.41 -46.98 29.48 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -107.65 107.51 18.34 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -89.34 -24.52 21.96 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.482 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.2 m -81.39 45.5 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.194 0.521 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -61.78 163.02 7.9 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.072 1.349 . . . . 0.0 112.251 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.5 t -49.31 -35.9 19.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.405 1.482 . . . . 0.0 111.722 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.5 p -57.57 -44.86 85.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 11.8 mptt -68.35 -50.63 51.88 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.824 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -47.48 -46.11 26.74 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.048 0.939 . . . . 0.0 111.714 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 m -66.87 -47.73 70.98 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.621 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -71.37 -33.78 69.86 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 28.9 mm-40 -66.43 -31.54 72.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.25 36.71 23.4 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.627 HG22 ' H ' ' A' ' 20' ' ' HIS . 61.5 mt -86.88 -72.42 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.174 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.09 -5.53 6.43 Favored Glycine 0 N--CA 1.471 0.971 0 CA-C-N 116.577 -0.283 . . . . 0.0 113.57 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.627 ' H ' HG22 ' A' ' 18' ' ' ILE . 41.3 t60 -70.2 110.75 5.37 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 123.292 0.637 . . . . 0.0 109.779 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 73.65 15.99 3.96 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.491 1.119 . . . . 0.0 110.983 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -122.43 81.36 46.42 Favored Pre-proline 0 N--CA 1.456 -0.13 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.93 -20.44 51.29 Favored 'Trans proline' 0 N--CA 1.479 0.624 0 C-N-CA 122.9 2.4 . . . . 0.0 112.866 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -102.46 6.09 39.91 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.809 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.2 m -135.14 72.05 1.45 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.298 0.571 . . . . 0.0 111.257 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -107.66 100.57 9.95 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.3 m -139.28 164.56 29.5 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.4 ptm85 -117.62 86.93 2.61 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.483 0.658 . . . . 0.0 110.429 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.5 m80 . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.61 172.43 13.15 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -99.89 173.36 6.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 120.917 0.389 . . . . 0.0 110.285 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.44 44.79 1.43 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.8 m -83.45 -44.75 14.42 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.268 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -130.0 107.78 9.6 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -76.42 -23.77 53.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.222 0.534 . . . . 0.0 110.432 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -87.76 16.72 5.42 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 11' ' ' SER . 36.0 t70 -74.89 113.08 11.77 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.4 t -62.83 -29.76 70.98 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.812 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 18.7 m -63.98 -46.82 82.88 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.22 -46.92 82.51 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' OE1' HD12 ' A' ' 18' ' ' ILE . 75.0 mm-40 -65.45 -29.39 70.06 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.886 -176.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.4 m -84.09 -33.18 24.44 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.233 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' SER . 32.4 mm-40 -67.67 -34.51 77.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.442 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -73.72 -38.37 64.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.31 52.13 1.77 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.774 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 ' OE1' ' A' ' 13' ' ' GLN . 56.6 mt -103.74 -77.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.11 69.61 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.598 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -127.32 125.42 40.78 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 77.01 14.77 1.96 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.378 1.071 . . . . 0.0 110.742 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -125.85 87.71 55.49 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.45 -13.09 38.04 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.126 2.551 . . . . 0.0 112.867 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -103.26 1.54 33.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.176 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.7 m -116.82 117.03 28.61 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.45 . . . . 0.0 111.593 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -107.65 100.56 9.95 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 m -101.58 142.79 32.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -70.4 -87.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 116.709 -0.223 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.58 -172.55 52.47 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 116.502 -0.317 . . . . 0.0 113.241 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.84 124.4 29.65 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.95 28.59 0.65 Allowed Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.372 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.3 m -142.58 -61.38 0.44 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.866 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -168.59 118.24 0.73 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -94.82 -15.16 23.97 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.897 0.38 . . . . 0.0 111.28 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.5 m -110.39 27.33 9.74 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 35.4 t70 -86.26 118.23 25.57 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.119 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.7 t -56.01 -38.05 69.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.76 0.663 . . . . 0.0 111.781 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.4 t -69.2 -36.13 76.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.964 0.411 . . . . 0.0 110.148 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.8 -39.15 84.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.052 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.2 mm-40 -61.28 -40.78 95.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.0 m -67.16 -38.61 85.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.226 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.89 -33.67 76.11 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.287 0.565 . . . . 0.0 110.381 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -85.01 -10.43 57.0 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.525 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.99 62.95 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.203 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.5 mt -82.83 -77.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.97 -10.34 5.67 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 116.385 -0.37 . . . . 0.0 113.549 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.533 ' H ' HG22 ' A' ' 18' ' ' ILE . 14.5 t-80 -76.54 122.07 24.05 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.041 0.536 . . . . 0.0 110.587 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp 70.7 18.35 6.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.19 0.996 . . . . 0.0 111.418 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 9.9 m-85 -122.12 87.9 47.92 Favored Pre-proline 0 N--CA 1.437 -1.085 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.59 -21.76 59.08 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.335 2.69 . . . . 0.0 114.09 -170.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -103.99 12.31 34.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.61 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 39.9 m -117.94 75.75 1.02 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.025 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -96.53 100.24 11.84 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.65 163.24 30.2 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.735 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -107.58 96.34 6.33 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.572 0.701 . . . . 0.0 111.717 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.59 80.25 0.28 Allowed Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.003 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.76 154.35 0.12 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.767 1.227 . . . . 0.0 111.962 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.69 50.17 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.347 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -109.64 -64.77 1.21 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.27 0.557 . . . . 0.0 110.326 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 15.5 t80 -95.51 129.03 42.83 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.438 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -140.98 12.03 2.22 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.945 0.878 . . . . 0.0 108.936 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 6' ' ' PHE . 20.8 t -80.68 0.51 34.05 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.855 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.62 118.49 5.7 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 t -60.87 -46.24 91.38 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.888 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 50.1 m -64.34 -28.81 69.96 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.46 -50.91 57.06 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -60.4 -32.6 71.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.94 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.0 m -69.55 -36.68 76.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.553 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 11' ' ' SER . 47.0 mt-10 -72.28 -34.47 68.21 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.433 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -76.32 -14.66 60.09 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.0 110.603 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.62 39.1 50.08 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 20' ' ' HIS . 47.5 mt -93.49 -85.11 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.94 -10.19 4.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.524 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' HG22 ' A' ' 18' ' ' ILE . 48.8 t60 -73.95 118.25 16.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.538 1.135 . . . . 0.0 109.079 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp 79.22 11.81 1.36 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.824 1.327 . . . . 0.0 110.584 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -125.02 86.39 56.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.0 -16.49 49.67 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.14 2.56 . . . . 0.0 113.072 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.45 2.11 47.41 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.444 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -115.65 77.35 1.08 Allowed 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.404 0.621 . . . . 0.0 111.851 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -107.93 108.28 19.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 76.3 m -138.36 157.08 46.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.316 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -70.65 -62.69 1.3 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.633 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.108 0 O-C-N 122.167 -0.333 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.64 -64.06 3.1 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -81.94 105.11 12.8 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 -4.07 60.64 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 m -72.52 -44.9 61.57 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.96 -0.62 . . . . 0.0 111.221 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -132.73 131.01 40.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.516 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -131.69 -5.96 3.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 m -74.19 30.55 0.08 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.607 0.763 . . . . 0.0 112.814 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 13.1 t70 -71.64 135.07 46.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.37 -34.49 76.79 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 123.624 0.578 . . . . 0.0 111.898 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.2 m -67.7 -29.83 69.19 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -73.51 -38.41 65.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.076 0.465 . . . . 0.0 110.808 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 42.9 mm-40 -67.95 -39.45 83.4 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.822 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.84 -26.75 59.92 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.813 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.25 -35.15 68.72 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.156 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.41 -15.75 45.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.231 0.538 . . . . 0.0 109.976 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.79 42.56 20.58 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.543 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 20' ' ' HIS . 39.4 mt -94.2 -78.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.19 -11.31 23.66 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.315 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.562 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.1 t-80 -79.48 124.31 28.36 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.014 0.526 . . . . 0.0 110.166 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 77.34 13.02 2.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.382 1.073 . . . . 0.0 111.409 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -124.37 88.26 53.24 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -17.05 47.05 Favored 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 123.535 2.824 . . . . 0.0 112.777 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -91.26 -8.82 47.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.891 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.1 m -107.38 93.23 4.43 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.202 0.525 . . . . 0.0 111.928 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.03 100.22 9.58 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.9 m -141.26 103.69 4.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -132.38 113.0 12.66 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.297 0.57 . . . . 0.0 112.077 -176.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.92 -140.37 9.11 Favored Glycine 0 N--CA 1.423 -2.214 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.236 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.52 -27.22 21.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.635 0.731 . . . . 0.0 109.818 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.75 92.41 0.3 Allowed Glycine 0 C--N 1.286 -2.207 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.976 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.1 m -67.75 -33.39 74.76 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.21 0.529 . . . . 0.0 110.814 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -137.86 149.14 46.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -52.46 -50.75 62.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.082 0.953 . . . . 0.0 110.641 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -76.71 96.75 4.28 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.599 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 18.7 t70 -108.16 127.42 53.8 Favored 'General case' 0 CA--C 1.492 -1.281 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.141 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.8 t -51.36 -42.74 61.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 124.071 0.948 . . . . 0.0 112.201 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 t -76.82 -31.12 56.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -66.23 -41.38 90.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 2.7 mm-40 -63.95 -34.34 77.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.792 0.806 . . . . 0.0 109.346 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 90.0 m -76.9 -23.84 52.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.628 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.63 -33.38 64.52 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.0 -18.23 40.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.423 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.41 44.68 6.83 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.839 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 20' ' ' HIS . 35.8 mt -96.11 -88.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 122.539 -0.389 . . . . 0.0 110.084 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.65 -10.48 37.95 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 121.309 0.394 . . . . 0.0 112.227 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' ILE . 12.5 t60 -70.11 114.65 8.47 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.348 1.059 . . . . 0.0 109.931 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 74.92 13.74 3.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 124.634 1.173 . . . . 0.0 112.339 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 6.4 m-85 -121.77 84.27 43.51 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.08 -17.58 40.58 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 123.339 2.693 . . . . 0.0 112.732 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -93.83 1.11 56.51 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.7 m -112.21 96.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.75 102.82 15.44 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.0 m -80.29 150.56 29.93 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.46 90.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.076 1.351 . . . . 0.0 112.154 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.282 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 160.14 14.85 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.061 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 17.08 3.41 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.04 57.07 0.56 Allowed Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.761 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.3 m -68.12 -44.48 76.03 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.616 0.722 . . . . 0.0 110.405 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -128.0 116.52 20.17 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -110.27 -15.98 13.85 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.108 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -81.81 14.57 2.62 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 9.0 m-20 -54.01 129.31 33.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 122.636 0.374 . . . . 0.0 110.734 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.71 -40.17 96.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.02 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -63.61 -34.32 77.57 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.936 0.398 . . . . 0.0 110.011 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.548 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 87.2 tttt -69.62 -40.99 76.25 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.046 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 72.3 mm-40 -67.06 -28.39 68.16 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -78.22 -35.14 48.81 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.523 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.2 pt-20 -73.74 -31.39 63.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.906 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.49 -23.77 58.91 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.78 47.02 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.714 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 20' ' ' HIS . 48.0 mt -94.0 -78.74 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.486 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 -11.2 12.26 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 116.616 -0.265 . . . . 0.0 113.33 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.632 ' H ' HG22 ' A' ' 18' ' ' ILE . 28.4 t-80 -75.96 123.79 26.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 79.68 10.54 1.38 Allowed 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 124.184 0.927 . . . . 0.0 110.914 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.52 88.5 46.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.33 -35.15 74.86 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 113.362 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -90.64 -9.11 48.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.349 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.6 m -94.1 69.83 3.84 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.039 0.923 . . . . 0.0 110.903 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -108.4 101.67 10.84 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.869 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.2 m -114.67 154.15 28.94 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.96 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -83.79 82.5 8.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.459 0.647 . . . . 0.0 111.405 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.164 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.2 t60 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.6 17.2 34.18 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.215 -0.517 . . . . 0.0 111.951 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -60.05 143.44 51.98 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 122.853 0.461 . . . . 0.0 110.592 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.78 -50.38 1.38 Allowed Glycine 0 C--N 1.298 -1.531 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.3 m -79.08 -44.71 21.57 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -131.2 122.11 26.0 Favored 'General case' 0 N--CA 1.399 -3.022 0 CA-C-N 114.561 -1.199 . . . . 0.0 108.401 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' SER . 2.5 t -108.61 -48.64 3.28 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 7' ' ' THR . 15.1 t 163.63 97.85 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.019 1.728 . . . . 0.0 107.956 173.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.7 t70 -92.38 120.26 32.71 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.4 t -58.88 -35.47 73.06 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 124.177 0.923 . . . . 0.0 111.383 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.1 t -66.92 -42.37 85.5 Favored 'General case' 0 N--CA 1.425 -1.698 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.163 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 9' ' ' ASP . 89.6 mttt -65.74 -41.11 92.57 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 46.4 mm-40 -57.25 -48.15 79.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.162 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.8 m -72.98 -32.44 65.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.3 -28.76 59.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.62 0.248 . . . . 0.0 110.969 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.92 -17.63 57.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.194 0.521 . . . . 0.0 109.643 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.79 16.84 Favored Glycine 0 CA--C 1.497 -1.069 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.67 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 20' ' ' HIS . 32.6 mt -95.95 -87.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.834 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.11 30.23 72.02 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.439 ' H ' HG22 ' A' ' 18' ' ' ILE . 18.8 t-80 -129.46 124.13 33.29 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 75.8 20.48 1.79 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.881 1.272 . . . . 0.0 110.425 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -128.86 92.25 40.55 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.99 -14.84 43.96 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 124.056 3.171 . . . . 0.0 114.439 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -96.97 7.49 46.54 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.946 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.6 m -129.61 116.04 18.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.953 0.406 . . . . 0.0 111.795 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -108.0 99.27 8.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.4 m -146.67 163.62 35.3 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -71.46 -74.24 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 123.824 0.702 . . . . 0.0 110.948 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.83 -7.47 12.03 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.76 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 73.71 85.68 0.11 Allowed 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.493 1.117 . . . . 0.0 111.74 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.25 131.78 3.94 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -62.34 -42.68 99.59 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.317 0.647 . . . . 0.0 110.328 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -121.15 138.17 54.33 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -59.74 -50.53 73.47 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.508 0.505 . . . . 0.0 110.804 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 m -85.03 35.27 0.57 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.61 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 10.1 t70 -73.21 113.42 10.25 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 9.0 t -56.13 -31.04 62.95 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 124.016 0.822 . . . . 0.0 112.776 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -72.52 -45.99 56.76 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.805 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD3' ' CG ' ' A' ' 9' ' ' ASP . 10.9 mptt -70.56 -42.58 70.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.184 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 4.9 mm100 -62.93 -37.3 86.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.275 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 83.7 m -76.76 -23.51 52.96 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.259 -0.976 . . . . 0.0 112.492 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -69.73 -24.55 63.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.747 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -84.13 -25.42 29.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.709 0.766 . . . . 0.0 109.072 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.52 32.49 37.69 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 19' ' ' GLY . 12.3 pt -88.55 -68.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 18' ' ' ILE . . . 74.7 -11.13 7.58 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 114.269 0.468 . . . . 0.0 114.269 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HG2' ' A' ' 21' ' ' LYS . 73.1 t60 -71.09 113.36 8.04 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 74.4 mmtt 82.81 13.94 0.43 Allowed 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 124.862 1.351 . . . . 0.0 111.247 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.8 77.22 70.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 -12.63 29.77 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.434 2.756 . . . . 0.0 112.685 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -96.82 11.21 36.54 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.528 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.682 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 63.0 m -132.02 139.26 48.53 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -107.53 98.59 8.18 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -107.83 30.67 6.12 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 122.053 0.93 . . . . 0.0 108.551 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -68.37 104.29 1.84 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.175 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.411 0 CA-C-N 116.757 -0.201 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.593 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' OE1' ' HB ' ' A' ' 5' ' ' THR . 10.5 pt-20 -104.67 158.98 16.13 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.01 23.0 6.26 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.507 ' HB ' ' OE1' ' A' ' 3' ' ' GLU . 56.4 m -87.15 -69.04 0.71 Allowed 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.532 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -109.58 149.67 29.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.635 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -64.55 -44.96 89.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.694 1.198 . . . . 0.0 112.27 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.7 t -74.99 100.92 4.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.61 0.719 . . . . 0.0 110.778 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -143.72 123.43 13.36 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.18 -28.3 69.3 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.923 -174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 m -70.14 -37.15 75.2 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 9.3 mtpm? -73.44 -45.03 56.76 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.337 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.446 ' OE1' HD12 ' A' ' 18' ' ' ILE . 76.0 mm-40 -66.67 -31.11 71.58 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 28' ' ' ARG . 92.3 m -79.26 -20.96 46.82 Favored 'General case' 0 C--O 1.21 -1.021 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.178 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 35.9 tt0 -77.39 -34.3 54.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.767 0.794 . . . . 0.0 109.916 175.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -89.87 -9.38 49.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.557 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.45 38.23 90.74 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.267 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 20' ' ' HIS . 46.7 mt -98.54 -79.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.71 -10.94 35.89 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.252 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.582 ' H ' HG22 ' A' ' 18' ' ' ILE . 17.7 t-80 -77.83 124.82 28.46 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp 78.84 11.14 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.755 1.222 . . . . 0.0 110.741 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -127.17 87.57 56.21 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.56 -21.41 71.93 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.839 3.026 . . . . 0.0 113.251 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -86.24 -15.48 40.67 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.918 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m -101.54 82.65 2.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -107.41 100.17 9.63 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.6 m -140.38 -64.0 0.48 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.254 1.026 . . . . 0.0 111.094 -173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HD3' ' O ' ' A' ' 14' ' ' CYS . 5.6 ptm180 -146.04 92.45 2.2 Favored 'General case' 0 C--N 1.259 -3.338 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.546 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.247 -0.433 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.48 162.44 28.61 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -81.03 138.56 36.02 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.29 37.82 0.4 Allowed Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.1 m -57.73 -47.33 82.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.535 0.734 . . . . 0.0 109.859 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -133.51 139.91 46.92 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -65.47 -25.09 67.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.373 0.606 . . . . 0.0 111.043 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -105.13 32.51 4.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.263 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 6.2 m-20 -70.26 94.47 0.92 Allowed 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 22' ' ' TYR . 7.6 t -65.77 -33.09 75.06 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.273 0.558 . . . . 0.0 110.49 -174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.5 m -67.19 -33.82 76.2 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.346 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -69.38 -33.25 72.77 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.3 mm100 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.087 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 87.6 m -71.84 -39.66 69.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.37 -34.08 76.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.795 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.26 -19.86 52.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.05 0.452 . . . . 0.0 110.814 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.62 37.65 16.41 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.387 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 20' ' ' HIS . 34.1 mt -88.38 -79.35 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 15.24 71.55 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.901 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 18' ' ' ILE . 25.3 t-80 -105.55 120.45 41.66 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 77.9 19.86 1.07 Allowed 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.552 1.141 . . . . 0.0 111.193 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 8.4 m-85 -128.02 81.22 70.81 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.1 -35.73 91.52 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.845 2.363 . . . . 0.0 112.557 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -83.37 2.31 37.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.54 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 62.1 m -136.15 87.83 2.34 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.962 0.41 . . . . 0.0 110.047 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -95.6 100.17 11.94 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.96 123.11 25.3 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.582 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -81.66 98.5 8.41 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.351 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.91 71.63 2.71 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.804 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -120.41 92.72 3.84 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 121.835 0.826 . . . . 0.0 110.23 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.16 23.44 4.11 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.9 m -89.87 -46.49 8.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -120.49 147.59 44.93 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 m -147.42 -22.41 0.38 Allowed 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 m -71.91 77.74 0.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.758 0.79 . . . . 0.0 112.916 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 28.5 t70 -115.25 133.87 55.65 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 173.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 t -56.83 -44.25 81.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.747 0.655 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -66.8 -34.75 78.5 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.234 0.54 . . . . 0.0 110.338 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 38.5 ttmt -75.07 -39.46 60.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.668 -178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 29.6 mm-40 -70.18 -31.34 68.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 120.937 0.399 . . . . 0.0 110.03 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.6 m -69.1 -36.95 78.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.36 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 13.0 tp10 -73.5 -33.15 64.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.195 0.521 . . . . 0.0 111.106 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -74.06 -20.0 60.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.361 0.601 . . . . 0.0 109.842 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.54 41.84 8.15 Favored Glycine 0 CA--C 1.493 -1.317 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 20' ' ' HIS . 40.6 mt -101.22 -84.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.08 27.02 74.24 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.874 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' ILE . 29.2 t-80 -121.8 129.15 52.44 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt 75.62 14.64 2.77 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.533 1.146 . . . . 0.0 110.403 -175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -126.22 88.26 54.63 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -65.81 -5.32 11.66 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.858 3.039 . . . . 0.0 114.358 -172.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -115.27 7.13 15.14 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.458 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.0 m -116.81 87.94 2.8 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.261 0.553 . . . . 0.0 111.004 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -107.73 99.87 9.31 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.5 m -142.39 -174.76 4.22 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NH2' ' HA ' ' A' ' 15' ' ' GLU . 13.0 mmt180 53.2 -91.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.234 1.414 . . . . 0.0 113.478 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.263 0 O-C-N 122.064 -0.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 CA--C 1.514 -0.436 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 94.46 1.12 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 75.54 162.63 0.25 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.183 1.393 . . . . 0.0 112.45 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.35 25.57 2.87 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -71.26 -51.73 22.88 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.756 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -135.62 145.8 47.23 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.975 -168.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 20.3 m -143.16 14.18 1.85 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.498 1.142 . . . . 0.0 109.344 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t 63.15 39.45 9.85 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.36 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 33.2 t70 -68.04 119.1 12.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.754 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.33 -30.97 70.93 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.789 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' GLU . 48.8 m -65.39 -30.02 70.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.009 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -80.83 -34.96 33.47 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.195 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 54.3 mm-40 -71.14 -35.12 71.58 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.86 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.59 -18.05 46.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.492 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' SER . 28.2 tt0 -70.73 -35.15 72.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -81.44 -24.98 36.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.732 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.53 31.87 32.27 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.396 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.2 mt -88.61 -80.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.06 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.8 30.03 70.7 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.251 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -128.44 120.88 27.74 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 80.91 9.99 1.01 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.094 1.358 . . . . 0.0 109.903 -171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -129.42 89.44 47.41 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.7 -21.01 65.47 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.46 2.773 . . . . 0.0 113.515 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -96.18 10.73 36.82 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 123.793 0.837 . . . . 0.0 111.533 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.8 m -124.65 109.26 12.94 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.802 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -98.98 100.31 11.46 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.6 m -104.52 167.48 9.71 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -81.54 87.47 6.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.85 0.357 . . . . 0.0 110.094 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 116.733 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 CA--C 1.515 -0.39 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.26 154.89 25.15 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.82 152.55 20.38 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 117.6 0.7 . . . . 0.0 111.384 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.58 36.67 0.22 Allowed Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -77.04 -48.98 16.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.891 -0.654 . . . . 0.0 110.406 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 32.3 t80 -135.6 134.89 39.79 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.391 -171.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -140.76 11.99 2.27 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.613 0.721 . . . . 0.0 109.838 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 22.8 m -85.97 21.79 1.87 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.873 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.8 m-20 -63.35 99.58 0.2 Allowed 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.21 -40.45 94.01 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.538 -172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 t -65.66 -32.89 74.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 15' ' ' GLU . 30.0 mtpp -79.24 -28.43 42.44 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 6.9 mm100 -73.03 -35.71 66.81 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.1 m -71.5 -33.81 69.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.056 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 42.7 tt0 -57.92 -34.83 70.28 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.694 1.197 . . . . 0.0 111.1 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.07 -12.06 20.01 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.637 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.33 47.27 17.67 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 20' ' ' HIS . 41.9 mt -83.27 -73.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.41 -9.89 3.05 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 116.04 -0.527 . . . . 0.0 114.251 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.509 ' H ' HG22 ' A' ' 18' ' ' ILE . 59.6 t60 -70.1 114.79 8.6 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 122.907 0.483 . . . . 0.0 110.513 -176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 72.77 16.28 4.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 0.0 111.641 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -123.2 90.35 50.46 Favored Pre-proline 0 CA--C 1.513 -0.459 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.805 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 -22.54 23.15 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.484 2.122 . . . . 0.0 111.102 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -88.04 -7.41 57.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.785 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.6 m -132.91 71.95 1.48 Allowed 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 111.189 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -107.51 105.78 15.84 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.7 m -133.44 127.72 33.94 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -62.97 103.52 0.46 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 O-C-N 122.142 -0.349 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 78.5 t60 . . . . . 0 C--O 1.24 0.601 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.2 67.94 1.52 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -83.22 126.61 32.83 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.827 -0.687 . . . . 0.0 112.509 -171.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.51 -68.11 0.79 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.7 m -89.56 -74.86 0.46 Allowed 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.876 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 8' ' ' SER . 5.1 t80 -155.23 119.97 4.79 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.071 0.462 . . . . 0.0 110.292 -170.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 m -55.59 -43.55 76.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.602 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 6' ' ' PHE . 14.6 m -94.32 38.9 1.09 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.065 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 23.0 t70 -55.92 121.38 9.16 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.0 t -57.37 -36.54 71.36 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 124.093 0.871 . . . . 0.0 111.447 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.3 m -69.19 -42.85 75.27 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.06 -42.65 80.15 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.858 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' ASP . 19.4 mm-40 -65.89 -29.36 69.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.627 0.251 . . . . 0.0 111.272 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.6 m -78.97 -29.8 44.06 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.654 174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' SER . 45.6 mm-40 -73.17 -34.12 65.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.594 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.9 -23.91 58.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.183 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.61 49.75 5.3 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.46 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.6 mt -102.82 -83.71 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.57 30.38 70.98 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.66 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -128.23 120.32 26.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt 81.27 8.53 1.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.185 1.394 . . . . 0.0 110.111 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.05 89.73 50.64 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.71 -3.82 13.42 Favored 'Trans proline' 0 N--CA 1.475 0.413 0 C-N-CA 123.412 2.741 . . . . 0.0 113.427 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -112.75 5.56 17.67 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.308 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.7 m -124.24 105.91 9.86 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.065 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.8 171.51 7.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.06 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -78.12 96.38 5.14 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 109.8 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 116.534 -0.303 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_